MedTrace Logo

Phone Enabled Implementation of Cessation Support

NCT05628389 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2025-07-01

No results posted yet for this study

Summary

The tobacco use burden in Lebanon is exceptionally high: 35% of adults are current cigarette smokers and 39% are current waterpipe smokers. Although the World Health Organization endorses evidence-based interventions for population-level tobacco dependence treatment, recommended treatments are not integrated as a routine part of primary care in Lebanon, as is the case in other low-resource settings. The objective of this proposal is to evaluate the comparative effectiveness of promising multi-component interventions for implementing evidence-based cessation treatment in Lebanon's national system of primary health care centers.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Educational materials

Patient educational materials to address insufficient knowledge about harms of tobacco use and cessation.

BEHAVIORAL

Phone counseling

Cessation counseling to address insufficient patient self-efficacy and motivation.

DRUG

Nicotine Replacement Therapy

Nicotine patches to address nicotine withdrawal symptoms in patients.

BEHAVIORAL

Provider training

Provider training to address insufficient knowledge and self-efficacy to deliver AAA/AAC to patients.

BEHAVIORAL

Electronic reminders

Electronic reminders to address the lack of integration of AAA/AAC into practice.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Florida

    lead OTHER

Principal Investigators

  • Ramzi Salloum, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-06
Primary Completion
2027-08-30
Completion
2027-08-31

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05628389 on ClinicalTrials.gov